Activist VenBio Wins Control of Immunomedics Board
VenBio gained four seats on Immunomedics' board of directors.
Following a shareholder vote, activist VenBio Select Advisor won a contentious proxy fight against Immunomedics (IMMU) - Get Report , of which it is the largest shareholder. VenBio gained 4 seats on the drug-maker's board of directors.
READ THE FULL STORY HERE: Activist Investor Wins Control of Immunomedics Board Following Shareholder Vote
This article was written by
.
